Progressive multifocal leukoencephalopathy associated with efalizumab use in psoriasis patients.
about
Nail PsoriasisTreatment-related progressive multifocal leukoencephalopathy: current understanding and future stepsConcordance of preclinical and clinical pharmacology and toxicology of therapeutic monoclonal antibodies and fusion proteins: cell surface targetsProgressive multifocal leukoencephalopathy: new conceptsJC Polyomavirus Abundance and Distribution in Progressive Multifocal Leukoencephalopathy (PML) Brain Tissue Implicates Myelin Sheath in Intracerebral Dissemination of InfectionPost-therapeutic relapse of psoriasis after CD11a blockade is associated with T cells and inflammatory myeloid DCsLong-term safety of biologics in the treatment of moderate-to-severe plaque psoriasis: review of current data.Drug-associated progressive multifocal leukoencephalopathy: a clinical, radiological, and cerebrospinal fluid analysis of 326 cases.Infection risk in patients on multiple sclerosis therapeutics.The Changing Landscape of Alopecia Areata: The Therapeutic Paradigm.Ongoing challenges in pharmacovigilance.Characteristics of progressive multifocal leukoencephalopathy clarified through internet-assisted laboratory surveillance in JapanPredictors and characteristics of seizures in survivors of progressive multifocal leukoencephalopathy.Rad51 activates polyomavirus JC early transcriptionCase report of a patient with progressive multifocal leukoencephalopathy under treatment with dimethyl fumarateExpanded CD8 T-cell sharing between periphery and CNS in multiple sclerosis.Crohn's Disease: Evolution, Epigenetics, and the Emerging Role of Microbiome-Targeted Therapies.Can We Repurpose FDA-Approved Alefacept to Diminish the HIV Reservoir?Islet transplantation in type 1 diabetes: ongoing challenges, refined procedures, and long-term outcomeHuman Polyomavirus JC monitoring and noncoding control region analysis in dynamic cohorts of individuals affected by immune-mediated diseases under treatment with biologics: an observational study.Deep-Sequence Identification and Role in Virus Replication of a JC Virus Quasispecies in Patients with Progressive Multifocal Leukoencephalopathy.The link between VLA-4 and JC virus reactivation.Human polyomavirus JC reactivation and pathogenetic mechanisms of progressive multifocal leukoencephalopathy and cancer in the era of monoclonal antibody therapies.Targeting T-cell migration in inflammatory bowel disease.Comparative efficacy of biologics in psoriasis: a review.Biologic agents in islet transplantation.Chemokine receptors in psoriasis.Biological therapies for psoriasis.T-cell trafficking and anti-adhesion strategies in inflammatory bowel disease: current and future prospects.Adaptor regulation of LFA-1 signaling in T lymphocyte migration: Potential druggable targets for immunotherapies?A risk classification for immunosuppressive treatment-associated progressive multifocal leukoencephalopathy.Immune reconstitution inflammatory syndrome associated with biologic therapy.B Cell Therapies, Approved and Emerging: a Review of Infectious Risk and Prevention During Use.Targeting vascular and leukocyte communication in angiogenesis, inflammation and fibrosis.A novel therapeutic paradigm for patients with extensive alopecia areata.Advances in targeting co-inhibitory and co-stimulatory pathways in transplantation settings: the Yin to the Yang of cancer immunotherapy.Cooperative roles of NF-κB and NFAT4 in polyomavirus JC regulation at the KB control element.Comorbidity as a predictor for drug survival of biologic therapy in patients with psoriasis.JC Polyomavirus Attachment and Entry: Potential Sites for PML Therapeutics.Progressive Multifocal Leukoencephalopathy and Monoclonal Antibodies: A Review.
P2860
Q22305813-54D775DD-844F-499B-99A2-C17A946466C6Q26823444-D6FD7850-B6E2-4449-94BA-DA9FA5642937Q26830569-63971AE8-C34A-499E-ADC0-ADC4423B01FDQ27016148-EA410D65-0396-4E1D-8E4B-0349D449B99BQ28552120-7FBD419E-BFDB-4167-A7EE-61E57E91974AQ28732143-46344F56-358C-42B3-9216-1703BFAA5466Q30574065-5CCC710C-F790-49D5-96E2-5708C320D4B6Q30815289-4388DCEF-59A1-4987-85C6-A44ABDCDC76AQ30908652-CD7AA138-A736-436D-9708-06BB89C3C149Q33890805-A7E6E4BA-BC37-4AB8-8817-8EB058EE1278Q34417013-B5094DBF-807D-4295-B151-895DF6306884Q34445672-2DD9DD59-149A-4626-AFF8-5E8CCB74DCC0Q34505467-50DC3DED-B9A6-4744-A235-09E3D1621520Q35326474-0C34E7EF-F76C-451D-AF61-1E6BA242B246Q35685505-A572DEB8-B97E-4AAF-BF7F-5D74173452FFQ35777258-5C5C287F-2E83-4336-8289-AD79F70B9E0EQ35933419-2DB932A2-4A40-4165-A570-879C4E629D38Q36827134-CB036792-0C48-46A1-AEA4-C4BFECC75AA1Q37088225-887C5B39-8CB6-4292-81ED-9A2D5B61DA08Q37361949-4CC29F75-4DAA-499E-B6C1-B8A190C28911Q37512929-2510C42D-0D3E-4A26-9000-C03F57B59C24Q37965603-7077ACFE-2FEF-44AE-85FD-DE4AA3572056Q37980042-B092A706-F173-4534-90F0-51688B32CFFCQ38040430-DE08E92B-2D9F-4887-A364-1019EBBD3BD8Q38042475-28D6ECA4-B06A-4139-89BD-DC5FFCED2D85Q38126884-58E1EB8B-9E59-4D16-A324-D263B4096B0DQ38144211-CA0B025D-3103-4C96-B23F-AF97FE3FD2DCQ38155648-A0789894-DDEC-4448-BF59-97EC221A7397Q38181018-FA6A4315-A3A6-4B04-886C-CA90F4064609Q38253927-F8AD872A-6BE7-4BE6-9B4D-19BB1D6A8129Q38268951-60C6A8BF-EC75-4699-BAD8-B66A1FF23890Q38287572-D6A8B1D2-B0BC-4037-8197-80299711454CQ38569860-CB8FD236-099C-440D-8544-A5462A9009E8Q38650120-EEF513C2-1D5B-44C2-8250-EB6307235535Q38831003-8DB7AC41-99F7-4C51-BF01-302D45E124B3Q39161011-03BD71C0-5271-4F5F-B0D6-8D83FFF3110EQ39322234-90F9EF82-8A19-45E7-ACF9-2096FAA58B06Q40427746-ABB7C2D9-F01C-457D-8A0C-DCF2CFA82E28Q41921811-B80FAB5C-FD8C-4551-938A-514D6E08657AQ41924854-9F1BBB40-F429-470B-AE7C-12C3C260F5ED
P2860
Progressive multifocal leukoencephalopathy associated with efalizumab use in psoriasis patients.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Progressive multifocal leukoen ...... mab use in psoriasis patients.
@en
Progressive multifocal leukoen ...... mab use in psoriasis patients.
@nl
type
label
Progressive multifocal leukoen ...... mab use in psoriasis patients.
@en
Progressive multifocal leukoen ...... mab use in psoriasis patients.
@nl
prefLabel
Progressive multifocal leukoen ...... mab use in psoriasis patients.
@en
Progressive multifocal leukoen ...... mab use in psoriasis patients.
@nl
P2093
P1476
Progressive multifocal leukoen ...... mab use in psoriasis patients.
@en
P2093
Allen Brinker
Gerald Dal Pan
Ida-Lina Diak
Mark Avigan
Namita Kothary
Shewit Bezabeh
P304
P356
10.1016/J.JAAD.2010.05.033
P407
P577
2011-04-22T00:00:00Z